an immunogen used to raise antibodies against gastrin; Gastrimmune, consisting of a nonapeptide (the 9 amino acids of the amino terminal of human gastrin-17) conjugated to the large protein Diphtheria Toxoid, is a vaccine that raises gastrin-17-neutralizing antibodies in vivo and can be used to treat certain gastrointestinal malignancies.
Date introduced: March 18, 2004